AbbVie Inc.

AbbVie Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
1.51 B
Public Float
1.39 B
AbbVie Inc.
Stock Exchange Mexican Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
1.51 B
Public Float
1.39 B
AbbVie Inc.
Stock Exchange New York Stock Exchange
EPS
$3.49
Market Cap
$107.91 B
Shares Outstanding
1.48 B
Public Float
1.47 B

Profile

Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.

Financials

View All

Richard A. Gonzalez
Chairman & Chief Executive Officer
Rebecca Brown Roberts
Director